NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/11/2025
Voltar para busca
Dado oficial do USPTO
CEBIOTEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 7, 42
Data de depósito
29/09/2022
Data de registro
25/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/06/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
ES
Examinador
WATKINS, JONATHAN RALPH
Unidade examinadora
O40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized text "CEBIOTEX" in teal, to the left of a circular design in light blue, which is fragmented into many polygons formed by intersecting transparent straight lines. Two of the polygons therein are depicted in teal, while the rest are depicted in light blue.
Titulares e representantes
Titulares
CEBIOTEX, S.L.
Representantes
Justin R. Young DTL Ltd.
Classificação técnica
Classes Nice
Classe 5Classe 7Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents for administering pharmaceuticals in the form of films which facilitate administration of pharmaceutical products; biopharmaceuticals for cancer treatment; drug delivery compounds that facilitate the delivery of pharmaceuticals; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treating cancer; pharmaceutical preparations for oncological use; pharmaceutical preparations and substances for use in oncology; Veterinary products and substances for facilitating the delivery of pharmaceutical preparations; where all aforementioned goods exclude eye drops and pomades for ophthalmic or otorhinolaryngology use
Classe 7
3D printers; 3D bioprinters; three-dimensional (3D) living tissue manufacturing machines in the nature of 3D printers; machines for manufacturing medical and veterinary drugs, implants, and preparations
Classe 42
Bacteriological research and consultancy; consultancy relating to research and development in the field of therapeutic drugs; development of pharmaceutical preparations and medicines; development of pharmaceutical products; design of diagnostic apparatus and equipment; biotechnological research; scientific research for medical purposes in oncology; scientific research relating to chemistry; research regarding pharmaceutical products; medical research; stem cell research; biochemical research and analysis; research and development of products; conducting clinical trials for pharmaceutical products for others; scientific laboratory services; information and data systems design in the field of medical and veterinary research and development; pharmaceutical and medical research services; biomedical research services; research and development services in bacteriology; provision of medical and scientific research information regarding results of clinical trials relating to pharmaceutical products; information, advisory and consultancy services in relation to the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/12/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/12/2024
FIMP
FINAL DISPOSITION PROCESSED
09/12/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
25/06/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/05/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/04/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
17/04/2024
GPNX
NOTIFICATION PROCESSED BY IB
15/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/04/2024
PUBO
PUBLISHED FOR OPPOSITION
09/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/03/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/01/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
18/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/01/2024
RFNT
REFUSAL PROCESSED BY IB
04/09/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/08/2023
RFRR
REFUSAL PROCESSED BY MPU
17/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/07/2023
CNRT
NON-FINAL ACTION WRITTEN
18/07/2023
DOCK
ASSIGNED TO EXAMINER
14/07/2023
MAFR
APPLICATION FILING RECEIPT MAILED
22/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/11/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CEBIOTEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.